Sector: Health Care.Industry: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom.

Related Companies

TickerCompanyChg %Mkt Cap
CYCCPCyclacel Pharmaceuticals%

Cyclacel Pharmaceuticals Company Questions & Answers

Q

How do I buy Cyclacel Pharmaceuticals (CYCCP) stock?

A

You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ: CYCCP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cyclacel Pharmaceuticals's (CYCCP) main competitors?

A

Other companies in Cyclacel Pharmaceuticals’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Amgen (NASDAQ:AMGN).

Q

What is the target price for Cyclacel Pharmaceuticals?

A

There is no analysis for Cyclacel Pharmaceuticals

Q

How much is Cyclacel Pharmaceuticals (CYCCP) stock ?

A

The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCCP) is $7.65 last updated Fri May 07 2021 13:30:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Cyclacel Pharmaceuticals (CYCCP) dividend?

A

There are no upcoming dividends for Cyclacel Pharmaceuticals. The last dividend paid out to investors was $0.10 on 2018-10-12.

Q

When is Cyclacel Pharmaceuticals (NASDAQ:CYCCP) reporting earnings?

A

There are no earnings for Cyclacel Pharmaceuticals

Q

When is the upcoming split for CYCCP?

A

There is no upcoming split for Cyclacel Pharmaceuticals.